Gene Symbol | NDUFA13 |
---|---|
Entrez Gene | 51079 |
Alt Symbol | B16.6, CDA016, CGI-39, GRIM-19, GRIM19 |
Species | Human |
Gene Type | protein-coding |
Description | NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 13 |
Other Description | CI-B16.6|NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 13|NADH-ubiquinone oxidoreductase B16.6 subunit|cell death regulatory protein GRIM-19|cell death-regulatory protein GRIM19|complex I B16.6 subunit|complex I-B16.6|gene associated with retinoic and IFN-induced mortality 19 protein|gene associated with retinoic and interferon-induced mortality 19 protein |
Swissprots | Q6PKI0 Q9Y327 Q9H2L3 Q9P0J0 K7EK58 B4DF76 |
Accessions | EAW84826 Q9P0J0 AF261134 AAG44670 AF286697 AAG28167 AK293859 BAG57254 BC000589 AAH00589 BC009189 AAH09189 BG705222 BG724220 BM839920 BP230223 DB450544 NM_015965 NP_057049 |
Function | Accessory subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I), that is believed not to be involved in catalysis. Complex I functions in the transfer of electrons from NADH to the respiratory chain. The immediate electron acceptor for the enzyme is believed to be ubiquinone. Involved in the interferon/all-trans-retinoic acid (IFN/RA) induced cell death. This apoptotic activity is inhibited by interaction with viral IRF1. Prevents the transactivation of STAT3 target genes. May play a role in CARD15-mediated innate mucosal responses and serve to regulate intestinal epithelial cell responses to microbes. {ECO:0000269|PubMed:12628925, ECO:0000269|PubMed:12867595, ECO:0000269|PubMed:15753091}. |
Subcellular Location | Mitochondrion inner membrane; Single-pass membrane protein; Matrix side. Nucleus. Note=May be translocated into the nucleus upon IFN/RA treatment. |
Tissue Specificity | Widely expressed, with highest expression in heart, skeletal muscle, liver, kidney and placenta. In intestinal mucosa, down-regulated in areas involved in Crohn disease and ulcerative colitis. {ECO:0000269|PubMed:10924506}. |
Top Pathways | Alzheimer's disease, Huntington's disease, Non-alcoholic fatty liver disease (NAFLD), Oxidative phosphorylation |
Grim19 (C-5) - sc-365045 from Santa Cruz Biotechnology
|
||||||||||
Grim19 (F-10) - sc-365978 from Santa Cruz Biotechnology
|
||||||||||
Grim19 (H-10) - sc-514111 from Santa Cruz Biotechnology
|
||||||||||
Grim19 (56) - sc-136431 from Santa Cruz Biotechnology
|
||||||||||
Grim19 (C-1) - sc-271013 from Santa Cruz Biotechnology
|
||||||||||
Grim19 (H-71) - sc-99086 from Santa Cruz Biotechnology
|
||||||||||
Grim19 (1A8) - sc-66195 from Santa Cruz Biotechnology
|
||||||||||
Grim19 (G-15) - sc-324873 from Santa Cruz Biotechnology
|
||||||||||
Grim19 (Q-18) - sc-324874 from Santa Cruz Biotechnology
|
||||||||||
Anti-GRIM19 antibody - ab134325 from Abcam
|
||||||||||
Anti-GRIM19 antibody - ab88094 from Abcam
|
||||||||||
Anti-GRIM19 antibody - ab186848 from Abcam
|
||||||||||
Anti-GRIM19 antibody - ab190216 from Abcam
|
||||||||||
Anti-GRIM19 antibody - ab14500 from Abcam
|
||||||||||
Anti-GRIM19 antibody - ab93814 from Abcam
|
||||||||||
Anti-GRIM19 antibody - ab3449 from Abcam
|
||||||||||
Anti-GRIM19 antibody [EPR4471(2)] - ab109017 from Abcam
|
||||||||||
Anti-NDUFA13 / GRIM19 Antibody (aa159-172) - LS-C40693 from LifeSpan Bioscience
|
||||||||||
Anti-NDUFA13 / GRIM19 Antibody - LS-C82965 from LifeSpan Bioscience
|
||||||||||
Anti-NDUFA13 / GRIM19 Antibody - LS-C190880 from LifeSpan Bioscience
|
||||||||||
Anti-NDUFA13 / GRIM19 Antibody (aa1-30, AP) - LS-C223440 from LifeSpan Bioscience
|
||||||||||
Anti-NDUFA13 / GRIM19 Antibody (aa1-30, APC) - LS-C223441 from LifeSpan Bioscience
|
||||||||||
Anti-NDUFA13 / GRIM19 Antibody (aa1-30, Biotin) - LS-C223442 from LifeSpan Bioscience
|
||||||||||
Anti-NDUFA13 / GRIM19 Antibody (aa1-30, FITC) - LS-C223443 from LifeSpan Bioscience
|
||||||||||
Anti-NDUFA13 / GRIM19 Antibody (aa1-30, Azide-free, HRP) - LS-C223444 from LifeSpan Bioscience
|